Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “glp1 Agonist”

222 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 222 results

Not applicableEnded earlyNCT01303315
What this trial is testing

TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy

Who this might be right for
Diabetes Mellitus, Type 2
MetaCure (USA), Inc. 20
Large-scale testing (Phase 3)Study completedNCT01676116
What this trial is testing

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 438
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07411378
What this trial is testing

Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.

Who this might be right for
Muscle WastingObesity & OverweightObesity
Biophytis 164
Post-approval studies (Phase 4)Not Yet RecruitingNCT07100691
What this trial is testing

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Who this might be right for
Pulmonary Aspiration During Anaesthetic InductionGastric Emptying TimePreoperative Risk Assessment+1 more
Mater Misericordiae University Hospital 80
Post-approval studies (Phase 4)Looking for participantsNCT07163650
What this trial is testing

Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery

Who this might be right for
ObesityWeight LossMetabolic Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Large-scale testing (Phase 3)UnknownNCT05952882
What this trial is testing

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Who this might be right for
Polycystic Ovary SyndromeObesityInfertility, Female
Mỹ Đức Hospital 188
Large-scale testing (Phase 3)Study completedNCT00707031
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 639
Testing effectiveness (Phase 2)Study completedNCT01452451
What this trial is testing

Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Hanmi Pharmaceutical Company Limited 72
Post-approval studies (Phase 4)UnknownNCT05005741
What this trial is testing

The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.

Who this might be right for
Diabetes Mellitus, Type 2Overweight or Obesity
Second Xiangya Hospital of Central South University 120
Not applicableNot Yet RecruitingNCT07175805
What this trial is testing

Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy

Who this might be right for
Lower Urinary Tract SymptomsStress Urinary IncontinenceUrge Urinary Incontinence+6 more
Hartford HealthCare 200
Large-scale testing (Phase 3)Study completedNCT02735031
What this trial is testing

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Hypoglycemia
Radboud University Medical Center 10
Not applicableStudy completedNCT01281228
What this trial is testing

The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Obesity
Amsterdam UMC, location VUmc 48
Large-scale testing (Phase 3)Study completedNCT06489457
What this trial is testing

The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity

Who this might be right for
Type 2 Diabetes MellitusObesityFunctional Hypogonadism
University Medical Centre Ljubljana 25
Early research (Phase 1)Looking for participantsNCT07223216
What this trial is testing

Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants

Who this might be right for
Obesity
Biomea Fusion Inc. 80
Testing effectiveness (Phase 2)UnknownNCT04615871
What this trial is testing

Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19

Who this might be right for
Covid19Myocardial Injury
Vladimír Džavík 400
Large-scale testing (Phase 3)Looking for participantsNCT05305794
What this trial is testing

Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"

Who this might be right for
Double Diabetes
Centre Hospitalier Universitaire Dijon 76
Testing effectiveness (Phase 2)Study completedNCT07370922
What this trial is testing

Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

Who this might be right for
Transfusion Dependent Beta Thalassemia
Ain Shams University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06518837
What this trial is testing

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHER2-Negative Breast Cancer
Rutgers, The State University of New Jersey 40
Large-scale testing (Phase 3)Looking for participantsNCT07083154
What this trial is testing

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Who this might be right for
Dementia, MildMild Cognitive ImpairmentType 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 420
Load More Results